These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6861706)

  • 1. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
    Berson BS; Berntson GG; Zipf W; Torello MW; Kirk WT
    Endocrinology; 1983 Jul; 113(1):337-43. PubMed ID: 6861706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin-glycine and vasopressin-glycine-lysine-arginine on renal function in the rat.
    Lote CJ; McVicar AJ; Smyth DG
    J Endocrinol; 1986 Feb; 108(2):255-60. PubMed ID: 3950530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiuretic and pressor activities of vasopressin analogs with L-alaninamide and D-alaninamide substitutions at position 9.
    Buku A; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1984 May; 23(5):551-7. PubMed ID: 6547408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and stress-induced antinociception in the mouse.
    Hart SL; Oluyomi AO
    Br J Pharmacol; 1990 Feb; 99(2):243-6. PubMed ID: 2328392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat.
    Bodnar RJ; Wallace MM; Kordower JH; Nilaver G; Cort J; Zimmerman EA
    Ann N Y Acad Sci; 1982; 394():735-9. PubMed ID: 6960791
    [No Abstract]   [Full Text] [Related]  

  • 8. Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins.
    Jared SR; Rao JP; Subramani S
    Exp Physiol; 2009 Dec; 94(12):1174-84. PubMed ID: 19666695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin.
    Larsson LE; Lindeberg G; Melin P; Pliska V
    J Med Chem; 1978 Apr; 21(4):352-6. PubMed ID: 650663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
    Welch SP; Dewey WL
    J Pharmacol Exp Ther; 1986 Nov; 239(2):320-6. PubMed ID: 3095536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermia induced by centrally administered vasopressin in rats. A structure-activity study.
    Meisenberg G; Simmons WH
    Neuropharmacology; 1984 Oct; 23(10):1195-200. PubMed ID: 6549207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociception and paralysis induced by intrathecal dynorphin A.
    Herman BH; Goldstein A
    J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis.
    Machová A
    Physiol Res; 1992; 41(2):121-7. PubMed ID: 1286075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opioid peptide inhibition of the central actions of angiotensin.
    Summy-Long JY; Keil LC; Deen K; Rosella L; Severs WB
    J Pharmacol Exp Ther; 1981 Jun; 217(3):619-29. PubMed ID: 6262492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone.
    Yeung JC; Rudy TA
    J Pharmacol Exp Ther; 1980 Dec; 215(3):626-32. PubMed ID: 7441522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception.
    Welch SP; Cooper CW; Dewey WL
    J Pharmacol Exp Ther; 1986 Apr; 237(1):54-8. PubMed ID: 3958973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation by arginine- and desglycinamide-lysine-vasopressin of a centrally evoked pressor response.
    Versteeg CA; Bohus B; de Jong W
    J Auton Nerv Syst; 1982 Sep; 6(2):253-62. PubMed ID: 7175086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and adrenalectomy-induced sensitivity to morphine.
    Ratka A; De Kloet ER
    Eur J Pharmacol; 1988 Aug; 153(1):65-71. PubMed ID: 3215278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.